Biotech company revolutionizing the treatment of nerve damage. Creating innovative treatments for nervous system damage due to injury or disease
- Our Pipeline
First-in-class therapeutic peptide
Nervous System Damage
- Our Technology
Nervous system repair.
Developing innovative treatments
- Our Pipeline
Target big profits in this market with software stocks. New report reveals 3 top picks. New report reveals 3 top stocks experts predict are about to skyrocket. Download it free.
Search results
- The most optimistic Xilinx analyst has a price target of US$238 per share, while the most pessimistic values it at US$140. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.
People also ask
What is the forecast for Xilinx in 2023?
How much cash did Xilinx generate In fiscal 2022?
What is the outlook for Xilinx?
Who owns Xilinx Inc (xlnx)?
Is Xilinx a good stock to buy now?
Could Xilinx's 29% EPs beat lead to a re-rate?
Jan 27, 2022 · Shares of Xilinx Inc. XLNX rallied 1.4% during Wednesday’s extended trading session after the company reported overwhelming third-quarter fiscal 2022 results, wherein the top and bottom lines...
Find the latest Xilinx Inc (XLNX) stock forecast, 12-month price target, predictions and analyst recommendations.
Assess today's live Xilinx Inc (XLNX) share price, performance and insights using our live NASDAQ: XLNX stock exchange data. Analyse the historical data and Xilinx Inc share price performance...
Feb 15, 2022 · Analysts have used the AMD guidance for 2022 to derive a $4.02 EPS in 2022 and a $4.73 target for 2023. Xilinx has consensus analyst EPS targets of $4.66 for net income of $1.17 billion.
Feb 14, 2022 · OAKLAND, Calif., Feb 14 (Reuters) - Semiconductor designer Advanced Micro Devices Inc (AMD) (AMD.O) said on Monday it has finalized the purchase of Xilinx Inc (XLNX.O) in a record chip industry...
Xilinx Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.